VFA
IMMU

Virtus Fund Advisers’s Immunomedics Inc IMMU Stock Holding History

Virtus Fund Advisers’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$456K Buy
+28,196
New +$333K ﹤0.01% 333
2014
Q3 		– Sell
-7,055
Closed -$26K – 2205
2014
Q2 		$26K Buy
+7,055
New +$25.9K ﹤0.01% 2290

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Virtus Fund Advisers's IMMU Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Immunomedics Inc (IMMU) in Q4 2017: 28,196 shares worth $456K. The stake represents ﹤0.01% of the portfolio and ranks #333 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in IMMU as recently as Q2 2014.

Virtus Fund Advisers first reported a position in IMMU in Q2 2014 and has held it in 2 quarters since. 157 funds tracked by Wall St. Rank hold IMMU as of Q4 2017.

  • Virtus Fund Advisers held 28,196 shares of Immunomedics Inc worth $456K as of Q4 2017.
  • Immunomedics Inc was a new Virtus Fund Advisers position in Q4 2017.
  • Immunomedics Inc made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #333 holding.
  • Virtus Fund Advisers first reported a position in Immunomedics Inc in Q2 2014 and has held it in 2 quarters since.
  • 157 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.